11:30 PM Advancing Precision Nephrology & Podocyte Targeted Gene Therapies
Time: 11:30 am
day: Conference Day 2
Details:
- Sharing data on PS-001 for NPHS2 driven Focal and Segmental Glomerulosclerosis and PS-002 for complement driven glomerular diseases
- Exploring Phase 1 trial design considerations and including patient input
- Discussing next-steps in gene therapies for glomerular diseases
